We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
According to a new report, key trends that are occurring within pharma-biotech alliances, as well as within biotech-biotech alliances, are having to grapple with safety concerns and efficacy, which have made biotech a high-risk area for investment.
The Mozambican branch of the Roll Back Malaria campaign has announced a grant of $60 million from the Presidential Malaria Initiative, set up by U.S. President George Bush, to help fight the disease during the next three years.
Pennsylvania-based Locus Pharmaceuticals has submitted an investigational new drug (IND) application to the FDA to begin a Phase I human clinical study of the company's lead compound, LP-261, an orally administered small molecule for the treatment of cancer.
Trastuzumab (herceptin) should be used to treat women with early stage HER2 positive breast cancer except where there are concerns about cardiac function, according to draft guidance by the UK's National Institute for Health and Clinical Excellence (NICE).
Japan's Ministry of Health, Labor and Welfare has granted additional approval for Novartis' Neoral (cyclosporine), the company's proprietary immunosuppressant.
World-leading clinical research organisation (CRO) Covance has scored what it says is the biggest contract in its history -- a dedicated space agreement worth a minimum of $187m (€149m).
The first ever monoclonal antibody obtained starting from transgenic plants with the purpose of purifying a human vaccine has been registered with Cuban authorities, meaning cigars may not be the only application the country's tobacco is used for in the future.
Akzo Nobel's Nobilon International business, active in the field of human vaccines, is to work together with the Dutch Erasmus Medical Center's spin-off, CoroNovative BV, to expand and accelerate CoroNovative's virus discovery program.